For virologically suppressed adult patients with HIV-1. See Full Indication.

JULUCA | Innovative Pairing

An Innovative Pairing With Dolutegravir

The pairing of dolutegravir and rilpivirine inhibits the viral life cycle at 2 separate sites, like traditional 3-drug regimens

Mechanism of Action for 2-Drug Regimen JULUCA

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/viiv/julucahcp/10994778-moa.mp4

You may also be interested in

MILESTONES IN THE TREATMENT OF HIV-1

Read more »

CLINICAL TRIALS

Read more »

RISKS & SIDE EFFECTS

Read more »